edits.seer.internal.rules.IF38.xml Maven / Gradle / Ivy

Go to download
        <rule id="IF38" name="Primary Site, Morphology-Imposs ICDO2 (SEER IF38)" tag="N0009" java-path="lines.line" category="inter-field" depends="Histology_92-00_ICD-O-2,Primary_Site,Year_of_Diagnosis">
            <expression><![CDATA[Integer site = Functions.asInt(line.primarySite.substring(1))
Integer hist = Functions.asInt(line.histologyIcdO2)

if (hist == null || line.dateOfDiagnosisYear == null || line.dateOfDiagnosisYear > '2000')
   return true

return !((List)((Map)Context.IF38Table).getOrDefault(site, [])).contains(hist)]]></expression>
            <message>Impossible Site and Histology (92-00) ICD-O-2 combination</message>
            <description><![CDATA[This edit is skipped if Histology (92-00) ICD-O-2 is empty or year of Date of Diagnosis is greater than 2000 or blank.

The following site/histology combinations are considered to be impossible:

C480-C488 (Retroperitoneum & peritoneum)
  8720-8790 (Melanomas)

C300 (Nasal cavity)
  9250-9340 (Osteosarcomas--Giant cell, Ewing's, odontogenic)

C301 (Middle ear)
  9250-9340 (Osteosarcomas--Giant cell, Ewing's, odontogenic)

C310-C319 (Accessary sinuses)
  9250-9340 (Osteosarcomas--Giant cell, Ewing's, odontogenic)

C381-C388 (Pleura and mediastinum)
  8010-8245,8247-8671,8940-8941 (Carcinomas)
  8720-8790 (Melanomas)

C470-C479 (Peripheral nerves)
  8010-8671,8940-8941 (Carcinomas)
  8720-8790 (Melanomas)

C490-C499 (Connective tissue)
  8720-8790 (Melanomas)

C700-C709 (Meninges)
  8010-8671,8940-8941 (Carcinomas)

C710-C719 (Brain)
  8010-8671,8940-8941 (Carcinomas)

C720-C29 (Other central nervous system)
  8010-8671,8940-8941 (Carcinomas)

C400-C419 (Bone)
  8010-8060,8075-8671,8940-8941 (Carcinomas, except squamous cell)
  8720-8790 (Melanomas)

C760-C768 (Ill-defined sites)
  8720-8790 (Melanomas)
  8800-8811,8813-8830,8840-8920,9040-9044 (Sarcomas,except
    periosteal fibrosarcoma)
  8990-8991 (dermatofibrosarcoma)
  8940-8941 (Mesenchymoma)
  9120-9170 (Mixed tumor,salivary gland type)
  9240-9251 (Blood vessel tumor,Mesenchymal chondrosarcoma,
    and giant cell tumors)
  9540-9560 (Nerve sheath tumor
  9580-9581 (Granular cell tumor and alveolar soft part sarcoma)

Additional Information:

Combinations of site and type are designated as impossible by this edit because the combination is biologically impossible, i.e., the particular form of cancer does not arise in the specified site, or because standard cancer registry conventions have been established to code certain combinations in certain ways.

In reviewing these errors, it is important to understand the biology of the disease and the clinical picture and history of the individual case before deciding on a correct code.  It will often be useful to check medical references or to discuss specific problem cases with the registry's medical advisors.  The suggestions below are a starting point for analyzing an error, but are not a substitute for a medical decision.

Correction of these errors will usually require inspection of the abstracted text, either online or as recorded on a paper abstract.  Reference to the original medical record may also be required.

GENERAL

First review the case for the following:

1. Is the histologic type correctly coded?  If not, correct the histologic type code.  Note that the code for "Cancer" and "Malignancy" (8000/3) is NOT interchangeable with the code for "Carcinoma, NOS" (8010/3), which refers only to a malignancy of epithelial origin.

2. Is the primary site coded correctly?  Check whether the site coded as the primary site could be instead the site of metastatic spread or the site where a biopsy was performed.  If so, check for a more appropriate primary site.

SPECIFIC GUIDELINES

1. Retroperitoneum/Peritoneum and Melanomas:  If melanoma is identified in peritoneal or retroperitoneal tissue, it is almost certainly metastatic to that site.  Try to identify the primary site of the melanoma.  If no primary can be determined, the standard convention in cancer registries is to code the primary site as skin, NOS, C44.9, which puts the case in the most likely site group for analysis.  Most histologic type codes for melanomas in ICD-O-3 list skin, C44._, as the appropriate primary site.

2. Nasal Cavity/Middle Ear/Accessory Sinuses and Osteosarcomas: Osteosarcomas arise in bone, and the specified site code in ICD-O-3 is C40._ or C41._.  Osteosarcomas arising in the areas of the nose, middle ear, and sinuses should be assumed to have arisen in the bones of the skull and their primary site coded C41.0.

3. Pleura/Mediastinum and Carcinomas or Melanomas:  If a carcinoma or melanoma is identified in the pleura or mediastinum, it is almost certainly metastatic to that site.  Try to identify the primary site of the carcinoma or melanoma.  For a carcinoma, if no primary can be determined, code unknown primary site, C80.9.  For a melanoma, if no primary can be determined, the standard convention in cancer registries is to code the primary site as skin, NOS, C44.9, which puts the case in the most likely site group for analysis.  Most histologic type codes for melanomas in ICD-O-3 list skin, C44._, as the appropriate primary site.

4. Peripheral Nerves and Carcinomas or Melanomas:  If a carcinoma or melanoma is identified in peripheral nerves, it is almost certainly metastatic to that site.  Try to identify the primary site of the carcinoma or melanoma.  For a carcinoma, if no primary can be determined, code unknown primary site, C80.9.  For a melanoma, if no primary can be determined, the standard convention in cancer registries is to code the primary site as skin, NOS, C44.9, which puts the case in the most likely site group for analysis.  Most histologic type codes for melanomas in ICD-O-3 list skin, C44._, as the appropriate primary site.

5. Connective Tissue and Melanomas:  If a melanoma is identified in connective tissue, it is almost certainly metastatic to that site.  Try to identify the primary site of melanoma.  For a melanoma, if no primary can be determined, the standard convention in cancer registries is to code the primary site as skin, NOS, C44.9, which puts the case in the most likely site group for analysis.  Most histologic type codes for melanomas in ICD-O-3 list skin, C44._, as the appropriate primary site.

6. Meninges/Brain/Other CNS and Carcinomas:  If a carcinoma is identified in the brain, meninges, or other central nervous system, it is almost certainly metastatic to that site.  Try to identify the primary site of the carcinoma.  Check that the tumor is indeed a carcinoma and not "Cancer" or "Malignancy" which would be coded 8000/3.  If it is a carcinoma and no primary can be determined, code "Unknown primary site", C80.9.

7. Bone and Carcinomas or Melanomas:  If a carcinoma or melanoma is identified in the bone, it is almost certainly metastatic to that site.  Try to identify the primary site of the carcinoma or melanoma.  For a carcinoma, if no primary can be determined, code unknown primary site, C80.9.  For a melanoma, if no primary can be determined, the standard convention in cancer registries is to code the primary site as skin, NOS, C44.9, which puts the case in the most likely site group for analysis.  Most histologic type codes for melanomas in ICD-O-3 list skin, C44._, as the appropriate primary site.

8. Ill-defined Sites and Various Histologies:  Some histologic types are by convention more appropriately coded to a code representing the tissue in which such tumors arise rather than the ill-defined region of the body, which contains multiple tissues.]]></description>
            <history>
                <event version="SE11-001-07" user="greend" date="1991-09-15">Conversion of morphology and topography code from ICD-O-1 to ICD-O-2.</event>
                <event version="SE11-001-08" user="greend" date="1992-07-15">The site C400-C419 (bone) with histology 8070 is no longer an impossible combination.</event>
                <event version="SE11-001-09" user="greend" date="1993-05-07">The site C480-C488 (retroperitoneum &amp; peritoneum) with histology 8010-8671, 8940-8941 (carcinoma) is no longer an impossible combination.  The histology 8940 for site C760-C768 was correctly expanded to 8940-8941.</event>
                <event version="SE11-001-11" user="greend" date="1995-01-10">Edit no longer differentiates between in situ and malignant.</event>
                <event version="SE11-001-17" user="greend" date="2003-06-09">The following site/histology combinations are no longer considered &apos;impossible&apos;:
            C000-C009 8090-8096
            C199      8090-8096
            C209      8090-8096
            C210-C218 8090-8096</event>
                <event version="SE11-001-17" user="greend" date="2003-10-10">The following site/histology combinations are no longer considered impossible:
            C490-C499 8010-8671,8940-8941</event>
                <event version="SE11-001-18" user="greend" date="2004-10-05">The following site/histology combinations are no longer considered impossible: C381-C388 8246.</event>
                <event version="SE13-009-01" user="murphyr" date="2013-01-02" ref="66777">Updated description for the Ill-defined sites histologies.</event>
                <event version="SE16-016-08" user="depryf" date="2017-11-22" ref="67674">Edit syntax updated to allow pre-compilation optimization; no change in behavior.</event>
            </history>
        </rule>